Webinar on mining chemical libraries for new antibacterials

9 April 2019
Time: 17:00-18:30 CET

In this webinar, Carl Balibar (Merck Research Laboratories) will discuss screen design, target bias, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic.

GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

[Geneva/Padova – 4 March 2019] 

GARDP and Penta, the paediatric infectious diseases research network, have joined forces to tackle drug-resistant infections in children. The strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements; and trials with a focus on public health interventions to inform treatment guidelines.

Webinar on the various mechanisms of support offered by NIAID to facilitate discovery and development of anti-infectives

21 February 2019
Time: 17:00-18:30 CET

In this presentation, Ann Eakin (US National Institute of Allergy and Infectious Diseases, NIAID) provided an overview of the various mechanisms of support offered by NIAID to facilitate the discovery and development of drugs, vaccines, and diagnostics targeting infectious diseases. Dan Pevear, Senior Vice President, Biology and Grants Development, VenatoRx Pharmaceuticals, shared VenatoRx’ experience with NIAID support mechanisms.

Watch the webinar

German MOH continues supporting GARDP’s efforts to develop affordable antibiotics

[Geneva – 4 January 2019]
Funding supports developing antibiotics for important global health priorities
GARDP is pleased to receive a EUR 1.5 million investment from the German Federal Ministry of Health (MOH). This funding is already contributing to GARDP’s efforts to develop antibiotics for drug-resistant infections including sexually-transmitted infections and newborns with sepsis – both important global health priorities. The investment also supports GARDP’s growth as its incubation period, hosted by DNDi, comes to an end.

Antimicrobial Chemotherapy Conference 2019

15 January 2019
London, UK

Laura Piddock, Head of Scientific Affairs, and Astrid Pentz-Murr, Community manager REVIVE – session on tackling beta-lactamase mediated resistance
Emilie Alirol, Project Leader, Sexually Transmitted Infections – presentation on the development of a new drug for STIs

Research collaboration agreement seeks to address deaths in newborns from sepsis

[Liverpool, Geneva – 18 December 2018]
The University of Liverpool has signed a collaborative research agreement with GARDP in a bid to develop new treatment options for newborns with sepsis. The research seeks to explore the correct dose and frequency of potential antibiotic combinations that could improve treatment outcomes in this vulnerable population.